Peptide Hormones in Sports Drug Testing: Detection of Emerging Protein/Peptide-Based Drugs by Means of LC-MS

Now Available On-Demand

Therapeutic proteins and peptides have emerged as one of the most important classes of new pharmaceuticals. Several drug candidates with potential performance-enhancing properties are currently in preclinical or clinical development. The current version of the WADA Prohibited List includes a variety of protein/peptide-based doping agents, some of which can be detected in biological samples by using immunological and mass spectrometry-based approaches.

Dr. Katja Walpurgis and Andreas Thomas of the Center for Preventive Doping Research of the German Sport University Cologne will present novel classes of protein-/peptide-based drugs such as Fc-fusion proteins and discuss strategies for their detection in doping control samples by means of LC-MS.

What will I learn?

  • How novel protein-/peptide-based drugs such as Fc-fusion proteins and therapeutic antibodies can be detected in human matrices by using different proteomics techniques in combination with high resolution mass spectrometry.
  • How ion mobility can help to identify prohibited substances in complex biological matrices.

Who should attend?

  • Sports doping laboratories (human and animal doping)
  • Forensic toxicology laboratories
  • Drug testing laboratories
  • Institutes of legal medicine
  • Police forensic laboratories
  • State crime laboratories
  • People involved in toxicology research
  • People interested in detecting novel protein/peptide therapeutics

Dr Katja Walpurgis
Postdoctoral Researcher
Institute of Biochemistry, German Sport University, Cologne
View Biography
Dr Andreas Thomas
Senior Scientist, Institute of Biochemistry
German Sport University, Cologne
View Biography

Registration Details:

Our registration process uses cookies, by submitting this registration form you agree to our cookie policy.

(*) denotes required form field(s)